How We Do Harm A Doctor Breaks Ranks About Being Sick In America Otis Webb Brawley

Understanding What Dr. Otis Webb Brawley Actually Says About American Healthcare

The American healthcare system has structural problems that aren't going to fix themselves through better branding or more expensive insurance plans. Dr. Otis Webb Brawley, who spent decades as chief medical officer at the American Cancer Society before leaving in protest over the organization's acceptance of funding from companies making products linked to cancer, wrote How We Do Harm to explain exactly how the system works and why it keeps failing patients. The book isn't theoretical. He worked inside the machine long enough to know which levers actually move and which ones are just theater. The core argument is straightforward but hard to swallow for people who believe the system works if you just follow the rules and stay insured. Brawley documents how financial incentives run in the opposite direction of patient outcomes across multiple layers: insurance companies denying coverage, pharmaceutical pricing models, hospital administration priorities, and a medical education system that trains doctors to treat disease rather than prevent it. The profit motive doesn't corrupt the system occasionally. It was designed into the system from the ground up. I encountered this firsthand a few years ago when my father was dealing with a recurring cardiac issue that required specialist follow-up. The specialist was technically in-network, but the hospital where he operated had a separate billing entity that wasn't. The insurance company covered the office visit at 80 percent and then denied the surgery claim entirely, citing a loophole about "ancillary facility fees." We ended up paying out of pocket because appealing the denial would have taken six to eight weeks and my father wasn't waiting. That isn't an edge case. That's a standard operating procedure built into the contractual relationships between providers and payers. The system ran exactly as designed.

Brawley covers a lot of ground. He goes into detail about how statin drugs, which are among the most prescribed medications in the country, have questionable benefit profiles for primary prevention when you look at the actual data, yet the prescription engine never slows down because of industry marketing and guideline committees with conflicts of interest. He writes about the mammography screening debate, showing how earlier and more frequent screening created the appearance of better outcomes while actually increasing harm through overdiagnosis and unnecessary biopsies. He addresses how the FDA approval process for drugs prioritizes surrogate endpoints like tumor shrinkage over actual survival benefit, which means drugs can get approved and reimbursed even when they don't make patients live longer.

What the Book Gets Right That Other Critiques Miss

Most healthcare criticism focuses on cost or access. Brawley's contribution is documenting how the medical industry actively causes harm through the normal functioning of its incentive structure. It's not a bug. The overprescribing of opioids, the routine use of expensive imaging for conditions that would resolve on their own, the aggressive end-of-life treatment that extends suffering rather than extending life — these are rational responses to a system that rewards volume and intervention over outcomes and restraint. One counterintuitive point he makes is about preventive care itself. The assumption that more screening and earlier intervention is always better turns out to be wrong in several major areas. His discussion of PSA testing for prostate cancer is particularly well-reasoned. Widespread screening detected lots of cancers that would never have harmed the patient, leading to surgeries and radiation that caused incontinence and sexual dysfunction in men who never needed treatment. The medical establishment took decades to acknowledge this because admitting it would mean confronting the economic and professional incentives that drove the overtesting in the first place. Another nuance that doesn't get enough attention is his analysis of how medical training shapes behavior. Doctors are trained to act, to intervene, to order the test and prescribe the drug. Doing nothing is professionally difficult even when it's the medically correct choice. This creates a gap between what the evidence supports and what actually happens in clinical practice that no amount of continuing education closes because the structural pressure remains unchanged.

Where the Book Falls Short

The analysis is stronger on diagnosis than prescription. Brawley is excellent at explaining how the system causes harm and naming the institutions responsible, but the policy solutions he offers are thin. He advocates for value-based reimbursement models and stronger conflict-of-interest rules, which are correct but have been proposed in various forms for decades without meaningful implementation. The book doesn't convincingly address how to build political will for changes that threaten powerful stakeholders, including the medical profession itself. There's also a blind spot regarding the role of individual physicians. While Brawley is right that structural incentives drive most harmful behavior, he sometimes writes as if doctors are purely passive actors within the system. The reality is more complicated. Some physicians navigate around the incentives. They choose conservative management when guidelines push toward intervention. They push back against unnecessary testing. But the system makes this harder over time, and the ones who do resist often leave practice or burn out before mid-career, which Brawley touches on but doesn't fully develop.

Who Should Read This

People who want reassurance that their insurance plan is working for them shouldn't read this. People who are genuinely confused about why a reasonable person would want to live in a country where a covered hospital stay can still result in financial ruin will find this useful as a starting point, even though it won't give them a toolkit for navigating the system day to day. The practical takeaway is less about changing the system and more about entering it with your eyes open. If you're a patient, read it before your next major procedure or screening decision and ask your doctor specifically whether the intervention is treating a problem you actually have or solving a problem that exists primarily in the billing department. Not every doctor will appreciate the question, but the ones who do are the ones worth keeping. If you're in healthcare, read it and recognize yourself in the critique. The discomfort you feel is the system working as intended on the people inside it. The book came out in 2024 and is available through major booksellers and libraries. It's not a comprehensive policy manual. It's a reckoning from someone who spent his career inside the institutions and decided to speak about what he saw. The arguments hold up to scrutiny, and the examples are grounded in actual clinical experience rather than abstract ideology. That makes it one of the more honest accounts of American healthcare available, even if it doesn't tell you how to survive it.